| STARTUP | AMOUNT CHF | DATE | TYPE |
|---|---|---|---|
| Carewell SA | 1'500'000 | 03.08.2026 | Equity |
| AB2 Bio SA | 24'200'000 | 30.07.2026 | Revenue |
| Ahead Health AG | 8'200'000 | 29.07.2026 | Equity |
03.08.2026, hypt AG: CONCORDIA Case Study
13.07.2026, Hemetron AG: Hemetron for Rheumatology
04.07.2026, NextBusiness AG: infinity.swiss announces a USD 3M funding round to accelerate its development of autonomous accounting
02.07.2026, HeroSupport SA: The SHIELD clinical study ("Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy") was successfully initiated at NYU Langone Health’s (U.S.)
A vast offering of support programs for entrepreneurs, including
financing, networking events, trainings, and international roadshows